Barclays

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Page 220 of 226
ClearSign Technologies Corp
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
AstroNova, Inc.
Shares:41
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
232109108
Shares:53
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Atara Biotherapeutics, Inc.
Shares:1
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Athira Pharma, Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
184492106
Shares:86
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Barnes & Noble Education, Inc.
Shares:56
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Clean Energy Technologies, Inc.
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
SOCIETY PASS INCORPORATED.
Shares:12
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
BATTALION OIL CORP
Shares:314
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Beyond Air, Inc.
Shares:11
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
92206C870
Shares:10
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
ODYSSEY MARINE EXPLORATION INC
Shares:57
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
BeyondSpring Inc.
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Citius Pharmaceuticals, Inc.
Shares:29
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
BioAtla, Inc.
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Monopar Therapeutics
Shares:12
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
45783Y194
Shares:2
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Bionano Genomics, Inc.
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$175.9M)
Mural Oncology plc
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$175.9M)